UNRESECTABLE/METASTATIC COLORECTAL CANCER
Clinical trials for UNRESECTABLE/METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE/METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE/METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug JNJ-89402638 enters human trials for Tough-to-Treat GI cancers
Disease control Recruiting nowThis early-phase study is testing an experimental drug called JNJ-89402638 in people with metastatic colorectal or gastric cancer that has progressed after at least two prior treatments. The trial will first find the safest dose and schedule, then test the drug alone or combined …
Matched conditions: UNRESECTABLE/METASTATIC COLORECTAL CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Smart dosing: tailoring cancer drug levels could extend life for colorectal patients
Disease control Recruiting nowThis Phase 3 trial tests whether adjusting the dose of bevacizumab based on each patient's drug levels can better control metastatic colorectal cancer. About 244 people will receive either standard or personalized dosing alongside chemotherapy. The main goal is to see if personal…
Matched conditions: UNRESECTABLE/METASTATIC COLORECTAL CANCER
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New immunotherapy combo takes on advanced colorectal cancer
Disease control Recruiting nowThis trial tests a new immunotherapy called STC-1010 combined with standard chemotherapy and immune boosters in people with advanced colorectal cancer that cannot be removed by surgery. The study has two parts: first, finding the safest dose in about 21-33 participants, then test…
Matched conditions: UNRESECTABLE/METASTATIC COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Brenus Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC